Increasing evidence shows that PTEN-regulating miRs, such as miR-141-3p [10], miR-29a [11], miR-21 [12–16], miR-19a [17], miR-92a [18], and miR-486 [19] contribute to anti-tumor treatment resistance. This evidence concerns the gene PTEN and neoplasm.